Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Aciphex indications expanded

Feb. 19, 2002

Abbott/Ligand jointly identify selective glucocorticoid modulators

Feb. 18, 2002

COLAL-PRED enters late-stage trials for ulcerative colitis

Feb. 18, 2002

Positive preclinical and clinical results for NCX-1015 in IBD and arthritis

Feb. 18, 2002

New antibiotic with selective activity against H. pylori

Feb. 18, 2002

Eisai seeks FDA clearance for new indication of Aciphex/Pariet

Feb. 15, 2002

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

AstraZeneca identifies benzimidazoles for H. pylori infections

Feb. 11, 2002

Achillion to use ViroLogic's assays to evaluate antiviral product candidates

Feb. 11, 2002

Adolor conducts additional pivotal phase III trials of alvimopan in postoperative ileus

Feb. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...